CD8A and viral infectious disease: However, an in vivo study evaluated and compared the role of LAG-3 in both chronic and acute viral infections, resulting in a similar intrinsic cellular effect of LAG-3 in both cases, thus supporting the use of LAG-3 blockers to enhance CD8+ T cell responses [121].